Search for Clinical Trial Results

Sponsored By

Recurrent Respiratory Papillomatosis - 14 Studies Found

Status Study
Completed Study Name: Avelumab for People With Recurrent Respiratory Papillomatosis
Condition:
  • Recurrent Respiratory Papillomatosis
  • Juve
    Date: 2016-08-06
    Interventions: Drug: Avelumab Avelumab 10 mg/kg IV every 2 weeks for up to 6 doses.
Completed Study Name: Study of Anti-PD-1 Therapy for HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal and/or Pulmonary Involvement
Condition: Recurrent Respiratory Papillomatosis
Date: 2015-12-10
Interventions: Drug: Pembrolizumab 200 mg will be administered as a 30 minute IV infusion every 3 weeks on day 1 of eac
Active, not recruiting Study Name: Effect of Vaccination in Patients With Recurrent Respiratory Papillomatosis
Condition: Squamous Papilloma of the Larynx
Date: 2011-06-16
Interventions: Biological: Silgard vaccination with tetravalent antiviral vaccine
Withdrawn Study Name: Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease
Condition:
  • Lung Cancer
  • Malignant Mesothelioma
  • Metastatic Cancer

    • Date: 2008-08-12
    Interventions:
    • Procedure: bronchoscopic and lung imaging studies

<<< Previous